Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Moore

Showing results (1191-1200 of 1,421) with videos related to

Pageof 143
Sort By:
Plos One|June 27, 2017
Assessing the impact of Benzo[a]pyrene on Marine Mussels: Application of a novel targeted low density microarray complementing classical biomarker responsesMohamed Banni, Susanna Sforzini, Volker M Arlt, et al.
The Canadian Journal of Urology|February 28, 2007
Research priorities for urological care following spinal cord injury: recommendations of an expert panelK C Hayes, K Bassett-Spiers, R Das, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 2, 2026
Stereoselective, sex-dependent 5-HT<sub>2A</sub> receptor modulation of cortical plasticity by MDMA in miceMaya C Gaines-Smith, Justin M Silverman, Michael Fiorillo, et al.
JCI Insight|October 19, 2023
Vitamin D status associates with skeletal muscle loss after anterior cruciate ligament reconstructionYuan Wen, Christine M Latham, Angelique N Moore, et al.
BMC Genomics|April 1, 2017
Sparse feature selection for classification and prediction of metastasis in endometrial cancerMehmet Eren Ahsen, Todd P Boren, Nitin K Singh, et al.
Journal of Medicinal Chemistry|February 26, 2000
Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitorsC R Ganellin, P B Bishop, R B Bambal, et al.
Gynecologic Oncology|November 13, 2007
Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovaryKathleen N Moore, Katherine M Moxley, Amanda Nickles Fader, et al.
Gynecologic Oncology|March 6, 2024
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancerDebra L Richardson, Kathleen N Moore, Ignace Vergote, et al.
Gynecologic Oncology|August 15, 2019
Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218K N Slaughter Wade, M F Brady, T Thai, et al.
Gynecologic Oncology|December 25, 2012
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group studyEdwin A Alvarez, William E Brady, Joan L Walker, et al.
Pageof 143

Showing results (1191-1200 of 1,421) with videos related to

Sort By:
Pageof 143
Plos One|June 27, 2017
Assessing the impact of Benzo[a]pyrene on Marine Mussels: Application of a novel targeted low density microarray complementing classical biomarker responsesMohamed Banni, Susanna Sforzini, Volker M Arlt, et al.
The Canadian Journal of Urology|February 28, 2007
Research priorities for urological care following spinal cord injury: recommendations of an expert panelK C Hayes, K Bassett-Spiers, R Das, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 2, 2026
Stereoselective, sex-dependent 5-HT<sub>2A</sub> receptor modulation of cortical plasticity by MDMA in miceMaya C Gaines-Smith, Justin M Silverman, Michael Fiorillo, et al.
JCI Insight|October 19, 2023
Vitamin D status associates with skeletal muscle loss after anterior cruciate ligament reconstructionYuan Wen, Christine M Latham, Angelique N Moore, et al.
BMC Genomics|April 1, 2017
Sparse feature selection for classification and prediction of metastasis in endometrial cancerMehmet Eren Ahsen, Todd P Boren, Nitin K Singh, et al.
Journal of Medicinal Chemistry|February 26, 2000
Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitorsC R Ganellin, P B Bishop, R B Bambal, et al.
Gynecologic Oncology|November 13, 2007
Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovaryKathleen N Moore, Katherine M Moxley, Amanda Nickles Fader, et al.
Gynecologic Oncology|March 6, 2024
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancerDebra L Richardson, Kathleen N Moore, Ignace Vergote, et al.
Gynecologic Oncology|August 15, 2019
Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218K N Slaughter Wade, M F Brady, T Thai, et al.
Gynecologic Oncology|December 25, 2012
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group studyEdwin A Alvarez, William E Brady, Joan L Walker, et al.
Pageof 143